Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07437963) titled 'Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: National Cancer Institute (NCI)
Condition:
Recurrent Ganglioneuroblastoma
Recurrent Neuroblastoma
Refractory Ganglioneuroblastoma
Refractory Neuroblastoma
Intervention:
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Procedure: Computed Tomography
Drug: Cyclophosphami...